<p>Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer</p>

Abstract

Overall, PCH not only utilized the tumor microenvironment to control drug release, improve drug pharmacokinetics, and passively target the drug to the tumor tissue, but also exerted a synergistic anticancer effect. The acid-responsive PCH has enormous potential as a novel anticancer therapeutic strategy.